Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
SEC Suing Elon Musk to Testify About Twitter Purchase
The Securities and Exchange Commission is suing Elon Musk to compel testimony about his purchase of Twitter.
U.S. Economy Adds 336,000 Jobs in September
The U.S. economy added 336,000 jobs during September.
Stocks Fall After Jobs Report
Stocks fell in Friday's opening session after the release of stronger-than-expected jobs data.
U.S. Economy Adds 336K Jobs in September
U.S. Economy Adds 336K Jobs in September
The Average Long-Term U.S. Mortgage Rate Surges to 7.49%, Its Highest Level Since December 2000
The cost of financing a home surged again this week as the average long-term U.S. mortgage rate climbed to its highest level since December 2000, further dimming the affordability outlook for many would-be homebuyers.
A Commercial Fisherman in New York Is Convicted of Exceeding Fish Quotas by 200,000 Pounds
A commercial fisherman accused of conspiring with others to sell 200,000 pounds (90,000 kilos) of fish in excess of legal quotas has been convicted in federal court in New York.
Potential Airbag Recall Could Affect 52M Vehicles
Potential Airbag Recall Could Affect 52M Vehicles
Straight Talk Adds Walmart+ to Array of New Mobile Plan Features
Straight Talk Wireless is adding Walmart+ to the list of features meant to save customers money.
Ready4Work: Laid-Off Worker Looks to Secure New Role
A laid-off Google worker seeks to secure a new role.
